Join us for a one-hour, patient-focused town hall led by Drs. Marla Mendelson and Susan Kim!
Heart Health: Experts Discuss the Latest in Cardiovascular Disease and What Every Woman Needs to Know
May 3, 2019
Prentice Women’s Hospital, Room L
250 E Superior St, Chicago, IL 60611
Parking & Directions are available at the Northwestern Medicine website.
The event is free; however, please RSVP to secure your seat!
CME EVent Description
Heart disease from coronary artery disease is the number one killer of both men and women in the United States. As a result of differences in symptoms and disease presentation between genders, heart disease is often missed in women. Almost half of US women fail to recognize cardiovascular disease (CVD) as their major health problem and thus miss the opportunity to partner with health care providers early to identify and manage risk factors over their lifespan. Women are also at risk for other forms of heart disease such as valvular disorders, heart failure and arrhythmias. The aging woman is also at risk for bone loss and sexual dysfunction. It is critical for health care providers to identify and appropriately educate their female patients who are at risk for all forms of CVD. However, overall awareness, as well as rapid changes and advances in scientific discovery make the practice of evidence- based medicine challenging for all practitioners. The Bluhm Cardiovascular Institute’s Program for Women’s Cardiovascular Health invites you to attend the 11th Annual Women’s Cardiovascular Health Symposium. This year’s program will address a variety of cardiovascular topics commonly encountered in clinical practice. Key gender specific advances in a variety of areas of CVD, such as coronary artery disease, hypertension, lipid disorders, arrhythmias, hormonal changes and cardiac complications of cancer therapy will be covered. There will be ample time for participant interaction. We extend a special invitation for cardiologists, primary care providers and OB/ GYN physicians to attend this symposium since they can be the first to identify female patients at risk to personally and positively improve their overall health. Women are still less likely to be offered proven therapies for heart disease as compared to men. This troubling statistic is an urgent call to action to change, especially since the lifetime risk of CVD in women approaches.